Opening book details…
About this book
Exploring 1,2,3-triazole-Schiff’s base hybrids as innovative EGFR inhibitors for the treatment of breast cancer: In vitro and in silico study by Nareman A. Nawareg is a book available to read on EtoBox.
- Author
- Nareman A. Nawareg
- Publisher
- Elsevier Inc.
- Published
- 2025
- Language
- EN
More by Nareman A. Nawareg
Browse all works by Nareman A. Nawareg
Similar books
- Development of 1,2,3-triazole Hybrids as Multi-faced Anticancer Agents Co-targeting EGFR/mTOR Pathway and Tubulin Depolymerization — Mennatallah A. Shaheen (2025)
- Discovery of Novel Tris-1,2,3-triazole-based Hybrids as VEGFR2 Inhibitors with Potent Anti-proliferative and Cytotoxicity Through Apoptosis Induction — Mosa Alsehli (2025)
- Design and Synthesis of Betti Base Derivatives as EGFR Inhibitors — Xiaotian Xu (2025)
- Dialkyloxyphenyl Hybrids as PDE4B Inhibitors: Design, Synthesis, in Vitro / in Vivo Anti-inflammatory Activity and in Silico Insights — Aya M. Almatary (2025)
- Novel Thiazolidinedione Hybrids as Cholinesterase Inhibitors and Targeting Neuroblastoma: Design, Synthesis, in Vitro and in Silico Biological Evaluations — Gurbet Çelik Turgut (2025)
- Cytotoxic Potential of Novel Triazole-based Hybrids: Design, Synthesis, in Silico Evaluation, and in Vitro Assessment Against Cancer Cell Lines — Karpenko Yuriy (2025)